On Monday, H.C. Wainwright maintained its Buy rating and $70.00 stock target for Disc Medicine (NASDAQ: iRON), following the presentation of encouraging interim data from a Phase 1b study.
Disc Medicine is also developing treatments for anemia in Myelofibrosis (MF) and Chronic Kidney Disease (CKD), with Phase 1/2 data expected in the coming years. Disc Medicine has also made key ...
Look for trusted brands like Prestige, Butterfly, and Elica, offering stoves with features like auto-ignition, durable brass burners, and toughened glass tops for easy cleaning. Choose between 2 ...
The data presented at the 2024 American Society of Nephrology (ASN) Kidney Week in San Diego, CA demonstrated that a single dose of DISC-0974 results in sustained suppression of hepcidin and ...
Here’s how it works. Scientists have proposed a new type of data storage device that harnesses the powerful properties of quantum mechanics. The ultra-high-density optical memory device would ...
Nagano Fat Burning Tonic is a natural solution that is claimed to promote healthy weight loss in the body. The creator of the supplement says that this solution contains a proprietary blend of ...